Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C

Journal:

Clinical Infectious Diseases

Published:

2025-07-30

DOI:

10.1093/cid/ciaf305

Affiliations:

17

Authors:

19

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	3.000000	0.16
Harvard University, United States of America (USA)	2.000000	0.11
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	2.000000	0.11
Oswaldo Cruz Foundation (FIOCRUZ), Brazil	1.000000	0.05
Weill Cornell Medicine, United States of America (USA)	1.000000	0.05
Whitman-Walker Health (WWH), United States of America (USA)	1.000000	0.05
DLH, United States of America (USA)	1.000000	0.05
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.05
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.05
AbbVie, United States of America (USA)	1.000000	0.05
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.05
Denver Health Medical Center, United States of America (USA)	1.000000	0.05
Duke University Health System, United States of America (USA)	1.000000	0.05
Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG), United States of America (USA)	0.500000	0.03
University of California, San Francisco (UCSF), United States of America (USA)	0.500000	0.03
Hospital Nossa Senhora da Conceição, Brazil	0.500000	0.03
Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil	0.500000	0.03

Interested in Medical Microbiology?